Johnson Johnson Completes Divestiture of LifeScan to Platinu...
NEW BRUNSWICK, New Jersey, Oct. 2, 2018 /PRNewswire-AsiaNet/ -- Johnson & Johnson (NYSE: JNJ) today announced that it has completed the divestiture of its LifeScan business to Platinum Equity for approximately $2.1 billion. LifeScan, Inc. is a world leader in blood glucose monitoring and maker of the OneTo...
Read more https://view-release/?pr-id=75534